We are live on ! Find out more
FCP

Fidelis Capital Partners Portfolio holdings

AUM $1.4B
1-Year Est. Return 31.16%
This Fund
S&P 500
This Quarter Est. Return
+3.08%
1 Year Est. Return
+31.16%
3 Year Est. Return
+98.29%
5 Year Est. Return
10 Year Est. Return
AUM
$1B
AUM Growth
+$160M
Cap. Flow
+$123M
Cap. Flow %
12.26%
Top 10 Hldgs %
33.3%
Holding
459
New
47
Increased
265
Reduced
100
Closed
20

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$9.7M
2
AMD icon
Advanced Micro Devices
AMD
+$1.11M
3
AZN icon
AstraZeneca
AZN
+$1.02M
4
ELV icon
Elevance Health
ELV
+$1.01M
5
C icon
Citigroup
C
+$923K

Sector Composition

Rank Sector Weight
1 Technology 20.6%
2 Financials 9.23%
3 Consumer Discretionary 7.09%
4 Communication Services 6.43%
5 Healthcare 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEM icon
201
Agnico Eagle Mines
AEM
$90.5B
$736K 0.07%
7,755
HCA icon
202
HCA Healthcare
HCA
$89.5B
$721K 0.07%
2,157
-12
-0.6% -$4.19K
DUK icon
203
Duke Energy
DUK
$97.3B
$716K 0.07%
6,325
+1,167
+23% +$132K
TGT icon
204
Target
TGT
$68B
$716K 0.07%
5,335
-304
-5% -$43.6K
MSCI icon
205
MSCI
MSCI
$40.9B
$710K 0.07%
1,219
+49
+4% +$29.4K
AGG icon
206
iShares Core US Aggregate Bond ETF
AGG
$138B
$708K 0.07%
7,284
-4,323
-37% -$426K
IBB icon
207
iShares Biotechnology ETF
IBB
$9.77B
$706K 0.07%
5,118
-135
-3% -$19K
TMUS icon
208
T-Mobile US
TMUS
$190B
$705K 0.07%
2,963
+99
+3% +$22.5K
BRK.A icon
209
Berkshire Hathaway Class A
BRK.A
$1.12T
$697K 0.07%
1
AMT icon
210
American Tower
AMT
$80.4B
$693K 0.07%
3,740
+275
+8% +$57K
SUB icon
211
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$686K 0.07%
6,486
+2,577
+66% +$272K
BX icon
212
Blackstone
BX
$110B
$685K 0.07%
3,945
+1,571
+66% +$274K
AZO icon
213
AutoZone
AZO
$51.1B
$673K 0.07%
196
+29
+17% +$91.8K
NSC icon
214
Norfolk Southern
NSC
$75.1B
$672K 0.07%
2,686
+434
+19% +$110K
ADI icon
215
Analog Devices
ADI
$190B
$671K 0.07%
3,270
-181
-5% -$40K
ELV icon
216
Elevance Health
ELV
$85.5B
$659K 0.07%
1,626
-2,425
-60% -$1.01M
ASML icon
217
ASML
ASML
$669B
$651K 0.07%
890
-505
-36% -$363K
DLR icon
218
Digital Realty Trust
DLR
$71.7B
$650K 0.07%
+4,025
New +$714K
RCL icon
219
Royal Caribbean
RCL
$85.6B
$649K 0.06%
2,488
-119
-5% -$26.4K
PFE icon
220
Pfizer
PFE
$153B
$642K 0.06%
24,518
-1,317
-5% -$35.7K
SHEL icon
221
Shell
SHEL
$245B
$636K 0.06%
9,753
-8,276
-46% -$542K
IRM icon
222
Iron Mountain
IRM
$36.1B
$625K 0.06%
6,214
+279
+5% +$32.8K
GEV icon
223
GE Vernova
GEV
$264B
$621K 0.06%
1,718
+811
+89% +$254K
DHI icon
224
D.R. Horton
DHI
$42.3B
$614K 0.06%
4,469
+61
+1% +$10.2K
MDLZ icon
225
Mondelez International
MDLZ
$79.9B
$612K 0.06%
10,662
-1,543
-13% -$102K

Similar funds

Fidelis Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Fidelis Capital Partners held 459 positions worth $1B, up 19% from $840M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Fidelis Capital Partners deployed $123M of net new capital in Q4 2024, opening 47 new positions and adding to 265 existing holdings. Its largest new stake was State Street SPDR Dow Jones Industrial Average ETF Trust: 4,402 shares worth $1.96M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Lam Research, an estimated $9.7M trimmed.

  • Fidelis Capital Partners's largest Q4 2024 buy was State Street SPDR Dow Jones Industrial Average ETF Trust: 4,402 shares worth $1.96M.
  • Fidelis Capital Partners added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $12.1M increase.
  • Fidelis Capital Partners's biggest Q4 2024 reduction was Lam Research, cutting an estimated $9.7M.
  • Fidelis Capital Partners fully exited BP in Q4 2024, selling an estimated $490K.
  • Fidelis Capital Partners's ten largest holdings make up 33% of its $1B portfolio in Q4 2024.
  • Fidelis Capital Partners opened 47 new positions and closed 20 in Q4 2024.
  • Fidelis Capital Partners's portfolio value rose 19% quarter-over-quarter to $1B.

Based on Fidelis Capital Partners's 13F filing for Q4 2024, filed 6 Feb 2025.